Russell Investments Group, Ltd. Dyne Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$84.2 Billion
Q3 2025

A detailed history of Russell Investments Group, Ltd. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 113,932 shares of DYN stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

113,932

Previous 43,925 159.38%

Holding current value

$2.15 Million

Previous $418,000 244.74%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$8.18 - $14.22 $572,657 - $995,499	70,007 Added 159.38%	113,932 $1.44 Million
Q2 2025 Aug 13, 2025	SELL	$6.81 - $14.78 $163,113 - $354,010	-23,952 Reduced 35.29%	43,925 $418,000
Q1 2025 May 13, 2025	SELL	$10.46 - $25.46 $510,991 - $1.24 Million	-48,852 Reduced 41.85%	67,877 $709,000
Q4 2024 Feb 13, 2025	SELL	$23.56 - $35.55 $158,676 - $239,429	-6,735 Reduced 5.46%	116,729 $2.75 Million
Q3 2024 Nov 13, 2024	BUY	$31.94 - $47.04 $568,116 - $836,700	17,787 Added 16.83%	123,464 $4.43 Million

Q2 2024 Aug 08, 2024	BUY	$23.65 - $35.63 $88,309 - $133,042	3,734 Added 3.66%	105,677 $3.73 Million
Q1 2024 May 08, 2024	BUY	$13.06 - $29.18 $18,897 - $42,223	1,447 Added 1.44%	101,943 $2.89 Million
Q4 2023 Feb 05, 2024	SELL	$6.62 - $13.64 $308,823 - $636,306	-46,650 Reduced 31.7%	100,496 $1.34 Million
Q3 2023 Nov 13, 2023	BUY	$8.6 - $12.18 $308,241 - $436,555	35,842 Added 32.2%	147,146 $1.32 Million
Q2 2023 Aug 10, 2023	BUY	$8.53 - $14.28 $747,893 - $1.25 Million	87,678 Added 371.11%	111,304 $1.25 Million
Q1 2023 May 09, 2023	BUY	$10.88 - $15.0 $62,418 - $86,055	5,737 Added 32.07%	23,626 $272,000
Q4 2022 Feb 08, 2023	SELL	$9.37 - $13.8 $142,630 - $210,063	-15,222 Reduced 45.97%	17,889 $207,000
Q3 2022 Nov 04, 2022	BUY	$7.2 - $15.17 $238,399 - $502,293	33,111 New	33,111 $420,000
Q2 2021 Aug 04, 2021	SELL	$15.94 - $22.33 $111,946 - $156,823	-7,023 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$14.0 - $29.3 $98,322 - $205,773	7,023 New	7,023 $109,000

Others Institutions Holding DYN

# of Institutions

229

Shares Held

149M

Call Options Held

184K

Put Options Held

243K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $975M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Dyne Therapeutics, Inc. Transaction History